Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Results of operations
  2. 8-K Event Material agreement
  3. DEFA14A Proxy Proxy Materials
  4. DEF 14A Proxy Proxy Statement
  5. UPLOAD Other SEC-generated Letter
  6. PRE 14A Proxy Proxy Statement (Preliminary)
  7. 8-K Event Regulation FD disclosure · Other events
  8. S-3 Offering Registration Statement
  9. 10-K/A Report 10-K/A
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 8-K Event Other events
  15. SC 13G Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 5 Insider Annual Insider Trading Report
  18. 5 Insider Annual Insider Trading Report
  19. 8-K Event Other events
  20. 4 Derivatives Options or other derivatives

Page 25 of 30 · 584 filings